APA (7th ed.) Citation

Han, X., Jiang, X., He, J., Zheng, G., Xiong, Y., Wen, Y., . . . Cai, Z. (2024). Clinical outcomes of pomalidomide‐based and daratumumab‐based therapies in patients with relapsed/refractory multiple myeloma: A real‐world cohort study in China. Cancer Medicine, 13(9), 1. https://doi.org/10.1002/cam4.7232

Chicago Style (17th ed.) Citation

Han, Xiaoyan, et al. "Clinical Outcomes of Pomalidomide‐based and Daratumumab‐based Therapies in Patients with Relapsed/refractory Multiple Myeloma: A Real‐world Cohort Study in China." Cancer Medicine 13, no. 9 (2024): 1. https://doi.org/10.1002/cam4.7232.

MLA (9th ed.) Citation

Han, Xiaoyan, et al. "Clinical Outcomes of Pomalidomide‐based and Daratumumab‐based Therapies in Patients with Relapsed/refractory Multiple Myeloma: A Real‐world Cohort Study in China." Cancer Medicine, vol. 13, no. 9, 2024, p. 1, https://doi.org/10.1002/cam4.7232.